Literature DB >> 28493378

Blood pressure control and cardiovascular risk in hypertensive patients with type 2 diabetes: The German T2Target registry.

Thomas Mengden1, Uwe Ligges2, Johanna Mielke2, Peter Bramlage3, Andrea Korzinek4, Walter Sehnert5.   

Abstract

Blood pressure control in patients with type 2 diabetes and hypertension is poor. It is unclear how effectively general practitioners assess and treat such patients. T2Target included hypertensive patients with type 2 diabetes mellitus who had undergone ambulatory blood pressure monitoring within the past 3 months. Recordings were analyzed by the general practitioner and an independent center and the conclusions were compared. Nighttime hypertension was reported less frequently by the general practitioner in comparison with central assessment (43.9% vs 77.9%, P<.001), as were masked (4.0% vs 13.1%, P<.001) and isolated office (4.4% vs 8.8%, P<.001) hypertension. A total of 13.9% of patients were deemed to have controlled blood pressure (ambulatory blood pressure monitoring). For the 784 patients with uncontrolled blood pressure, 40.7% underwent no change to their antihypertensive treatment. Cardiovascular risk was underestimated, with 11.1% deemed to be at very high risk, in contrast to the 97.0% of patients by central assessment. In conclusion, blood pressure control in hypertensive patients with type 2 diabetes mellitus is poor and not accurately assessed by office-based general practitioners, despite the use of ambulatory blood pressure monitoring. ©2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  ambulatory; antihypertensive drugs; cardiovascular risk; comorbidities; diabetes; masked; white coat

Mesh:

Year:  2017        PMID: 28493378      PMCID: PMC8030940          DOI: 10.1111/jch.13001

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  24 in total

1.  Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community.

Authors:  D M Lloyd-Jones; J C Evans; M G Larson; C J O'Donnell; E J Roccella; D Levy
Journal:  Hypertension       Date:  2000-10       Impact factor: 10.190

2.  Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure.

Authors:  Guanmin Chen; Finlay A McAlister; Robin L Walker; Brenda R Hemmelgarn; Norm R C Campbell
Journal:  Hypertension       Date:  2011-03-14       Impact factor: 10.190

3.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

4.  Hypertension control: how well are we doing?

Authors:  Ann M Borzecki; Ashley T Wong; Elaine C Hickey; Arlene S Ash; Dan R Berlowitz
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

5.  Evaluating the treatment of hypertension in diabetes mellitus: a need for better control?

Authors:  Reginald P Sequeira; Khalid A Jassim Al Khaja; Awatif H H Damanhori
Journal:  J Eval Clin Pract       Date:  2004-02       Impact factor: 2.431

6.  The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure.

Authors:  Eve A Kerr; Brian J Zikmund-Fisher; Mandi L Klamerus; Usha Subramanian; Mary M Hogan; Timothy P Hofer
Journal:  Ann Intern Med       Date:  2008-05-20       Impact factor: 25.391

7.  European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).

Authors:  Joep Perk; Guy De Backer; Helmut Gohlke; Ian Graham; Zeljko Reiner; Monique Verschuren; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germano; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Eva Prescott; Lars Ryden; Martin Scherer; Mikko Syvänne; Wilma J M Scholte op Reimer; Christiaan Vrints; David Wood; Jose Luis Zamorano; Faiez Zannad
Journal:  Eur Heart J       Date:  2012-05-03       Impact factor: 29.983

Review 8.  Factors influencing the systolic blood pressure response to drug therapy.

Authors:  Carlos Campo; Julián Segura; Luis M Ruilope
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Jan-Feb       Impact factor: 3.738

9.  Changes in the prevalence, treatment and control of hypertension in Germany? A clinical-epidemiological study of 50.000 primary care patients.

Authors:  Alexander Michael Labeit; Jens Klotsche; Lars Pieper; David Pittrow; Franziska Einsle; Günter Karl Stalla; Hendrik Lehnert; Sigmund Silber; Andreas Michael Zeiher; Winfried März; Martin Wehling; Hans-Ulrich Wittchen
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

10.  Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies.

Authors:  Ina-Maria Rückert; Michaela Schunk; Rolf Holle; Sabine Schipf; Henry Völzke; Alexander Kluttig; Karin-Halina Greiser; Klaus Berger; Grit Müller; Ute Ellert; Hannelore Neuhauser; Wolfgang Rathmann; Teresa Tamayo; Susanne Moebus; Silke Andrich; Christa Meisinger
Journal:  Cardiovasc Diabetol       Date:  2012-05-08       Impact factor: 9.951

View more
  4 in total

1.  Hypertension and Health-Related Quality of Life (HRQoL): Evidence from the US Hispanic Population.

Authors:  Elizabeth Riley; Jongwha Chang; Chanhyun Park; Sean Kim; Inho Song
Journal:  Clin Drug Investig       Date:  2019-09       Impact factor: 2.859

2.  Understanding of hypertension and heart failure in patients with type 2 diabetes by studying effects of sodium-glucose cotransporter 2 inhibitors on plasma B-type natriuretic peptide levels.

Authors:  Hidekatsu Yanai; Hiroki Adachi; Mariko Hakoshima
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-12-01       Impact factor: 3.738

3.  Blood pressure control and cardiovascular risk in hypertensive patients with type 2 diabetes: The German T2Target registry.

Authors:  Thomas Mengden; Uwe Ligges; Johanna Mielke; Peter Bramlage; Andrea Korzinek; Walter Sehnert
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-05-11       Impact factor: 3.738

4.  Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study.

Authors:  Anna Solini; Giuseppe Penno; Emanuela Orsi; Enzo Bonora; Cecilia Fondelli; Roberto Trevisan; Monica Vedovato; Franco Cavalot; Olga Lamacchia; Marco G Baroni; Antonio Nicolucci; Giuseppe Pugliese
Journal:  BMC Med       Date:  2019-04-25       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.